Thursday, June 25, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 915 of 1,261

  1. US 8222215

    Methods for the use of inhibitors of antigen presentation by MHC class II molecules

    Provid Pharmaceuticals Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  2. US 8222282

    Sulfonate salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine

    Teva Pharmaceuticals USA, Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  3. US 8222242

    Nitric oxide releasing compounds

    The Regents of the University of California · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  4. US 8222293

    Treating learning deficits with inhibitors of Hmg CoA reductase

    Regents of the University of Carolina · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  5. US 8222421

    Certain substituted ureas, as modulators of kinase activity

    GILEAD CONNECTICUT, INC. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  6. US 8222392

    Kit for detection of telomerase reverse transcriptase nucleic acids

    The Regents of the University of Colorado · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  7. US 8222289

    Salinosporamides and methods for use thereof

    The Regents of the University of California · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  8. DE 102011080390

    Applikationshilfe

    ACINO AG [DE] · Granted Jul 12, 2012 · Expires Jul 7, 2032

    granted

  9. AU 2010323158

    Use of an oleo gel containing triterpene for healing wounds

    BIRKEN AG [DE] · Granted Jul 12, 2012 · Expires Jul 7, 2032

    granted

  10. US 8217066

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  11. US 8217015

    Endosomolytic polymers

    Arrowhead Madison, Inc. · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  12. US 8217166

    Polyethylene glycolated superoxide dismutase mimetics

    Galera Therapeutics, LLC · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  13. US 8216565

    GP100-specific T cell receptors and related materials and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  14. US 8217048

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  15. US 8216593

    Parasite vaccine

    The Board of Regents of the University of Texas System · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  16. US 8216580

    Sulfatases and methods of use thereof

    The Regents of the University of California · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  17. US 8217056

    Triazolothiadiazole inhibitor of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  18. US 8216594

    Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

    The Regents of the University of California · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  19. US 8216614

    Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis

    The Board of Regents of the University of Texas System · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  20. US 8217024

    Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

    TEVA WOMEN'S HEALTH, INC. · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  21. US 8217038

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  22. US 8217156

    Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  23. US 8217072

    Salinosporamides and methods for use thereof

    The Regents of the University of California · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  24. US 8217123

    Stabilized polymeric thiol reagents

    Nektar Therapeutics · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.